IDH1 and glioblastoma: Indeed, high expression of HOTAIR was able to identify a subgroup of HOXA9-negative IDH-wt GBM patients that presented a significantly shorter OS (median OS = 375 days) than those with low HOTAIR levels (median OS = 463 days; Supplementary Figure 3; Log-rank p = 0.037).